Menopause is a normal life transition, but it also changes the pattern of several health risks. Gout is one of them. Gout is less common in women before menopause and becomes more common later in life. That timing has led researchers to examine whether menopause itself, rather than age alone, is connected with changes in uric acid and the chance of developing gout.
The evidence supports an association, not a prediction for any one person. Menopause may be one part of the picture, while kidney function, genetics, other health conditions, body composition, diet, alcohol, and certain medicines can also influence urate levels and gout risk.
The short answer
Yes, menopause is associated with a higher risk of gout in population research. The National Institute of Arthritis and Musculoskeletal and Skin Diseases lists menopause and increasing age among factors that may increase the chance of developing gout. It also notes that women usually develop gout later than men and generally do not develop it before menopause.
This does not mean menopause directly causes gout in every woman. Most people who go through menopause will not necessarily develop gout, and many people with a high serum urate level never develop gout. A risk factor changes probability across groups; it does not establish an individual diagnosis.
Why uric acid matters
Uric acid is formed when the body breaks down purines, substances found naturally in cells and in many foods. In the blood, uric acid is mainly present as urate. The kidneys normally remove much of it through urine. When the body makes too much urate or removes too little, the blood level can rise.
Over time, persistently high urate can allow needle-shaped crystals to form in and around joints. The immune response to those crystals can produce the sudden pain, warmth, redness, and swelling of a gout flare. However, a blood test and a gout diagnosis are not interchangeable. A uric acid result is one piece of clinical information, and gout evaluation may also consider symptoms, examination, joint fluid, imaging, and other possible causes of joint pain.
What may change around menopause
Researchers have proposed that changes in estrogen may affect how the kidneys handle urate. Before menopause, estrogen may support urate excretion. When estrogen levels fall, average serum urate may rise. This is a biologically plausible explanation, but hormone changes occur alongside many other changes in health, medicines, and kidney function as people age.
An analysis of 7,662 women in the U.S. Third National Health and Nutrition Examination Survey found that both natural and surgical menopause were associated with modestly higher serum uric acid after adjustment for age and several other factors. Compared with premenopausal women, the adjusted average difference was about 0.34 mg/dL after natural menopause and 0.36 mg/dL after surgical menopause. Because this was a cross-sectional analysis, it identified a group-level association at one period in time; it could not prove that menopause caused the difference for each participant.
What a prospective gout study found
A separate Nurses' Health Study analysis followed 92,535 women who did not have gout at baseline. Over 16 years, researchers recorded 1,703 new cases of physician-diagnosed gout. After adjustment for age, body mass index, diuretic use, high blood pressure, alcohol, and dietary factors, postmenopausal women had a 26 percent higher relative risk of incident gout than premenopausal women.
Relative risk needs context. It compares rates between groups; it is not the same as saying that 26 percent of postmenopausal women will develop gout. In the same study, the observed incidence rose with age, from 0.6 cases per 1,000 person-years among women younger than 45 to 2.5 per 1,000 person-years among women age 75 or older. The research was observational, so it can show an association after statistical adjustment but cannot remove every possible source of confounding.
Menopause is only one part of risk
Gout usually results from several factors acting together over time. NIAMS identifies high urate, family history, increasing age, alcohol, sugar-sweetened beverages, and diets rich in animal-source purines among relevant factors. Chronic kidney disease, high blood pressure, metabolic syndrome, and obesity can also be associated with higher gout risk. Some medicines, including certain diuretics, can affect urate as well.
These factors are not a checklist for self-diagnosis. Their importance varies, and one factor may be related to another. For example, kidney function and medicine use can change with age. A clinician can interpret laboratory results and symptoms in that broader context. Medication decisions should be made with the prescribing clinician.
Hormone therapy is not a gout treatment conclusion
The two studies also reported associations between postmenopausal hormone use and lower serum uric acid or lower gout risk. Those findings do not establish hormone therapy as a way to prevent or treat gout. Observational comparisons can be influenced by differences between people who use hormone therapy and those who do not. The studies were not treatment trials designed to weigh all benefits and harms of hormone therapy for gout.
Hormone therapy has its own indications, contraindications, and health considerations. Decisions about it require an individualized discussion with a qualified clinician and should not be based on gout risk alone.
Useful information for a health conversation
If gout or high uric acid is a concern around or after menopause, a clear record can make a medical visit more productive. General information to note may include:
- When joint pain or swelling began, which joint was affected, and how long symptoms lasted.
- Whether the area became warm, red, or unusually tender.
- Prior uric acid results, with the date and the laboratory reference range.
- Known kidney problems, high blood pressure, diabetes, or kidney stones.
- A complete list of prescription medicines, over-the-counter products, and supplements.
- Family history of gout and any previous episodes of similar joint symptoms.
Sudden severe joint pain, redness, warmth, or swelling can have causes other than gout, including joint infection. Prompt medical assessment is important when symptoms are new, severe, accompanied by fever or illness, or otherwise concerning. An article cannot determine the cause.
Questions the evidence can help frame
Research about menopause and gout supports better questions, not automatic conclusions. Examples include whether a uric acid result should be interpreted alongside kidney function, whether current medicines may affect urate, and what tests are appropriate when joint symptoms are present. People with an established gout diagnosis may also ask how their overall risk profile changes with age.
The most useful next step depends on symptoms, health history, laboratory context, and clinical evaluation. Population averages cannot substitute for that assessment.
Bottom line
Menopause is associated with a modest rise in average serum uric acid and a higher relative risk of gout in observational studies. The connection is credible, but it is not destiny and does not prove that menopause alone caused a particular symptom or laboratory result. Understanding the association can help women recognize why gout becomes more common later in life and prepare focused questions for a clinician without turning a risk factor into a diagnosis.
Sources and further reading
- NIAMS: Gout Symptoms, Causes, and Risk Factors
- Hak and Choi (2008): Menopause, Hormone Use, and Serum Uric Acid in U.S. Women
- Hak et al. (2010): Menopause, Hormone Use, and Risk of Incident Gout